Doctor Michael Davies
Lexicon Pharmaceuticals, Inc., The Woodlands (United States of America)
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
/f/125658/3386x1417/951de003e4/hfa-acronym-name-rgb.png)
Sotagliflozin is effective in reducing heart failure risk of events in patients with HFpEF
Event: Heart Failure 2024
Topic: Pharmacotherapy
Session: Tailoring heart failure therapies on patient profiles
Efficacy and safety of the dual SGLT1 and 2 inhibitor sotagliflozin in combination with a mineralocorticoid receptor antagonist in patients hospitalized for worsening heart failure
Event: Heart Failure 2023
Topic: Pharmacotherapy
Session: ePosters in chronic heart failure - pharmacotherapy 2
